From June 5 to 7, 2026, the Second China Scar Treatment Technology Progress Conference was held in Shanghai. The conference was organized by the China Human Health Technology Promotion Association and brought together experts and scholars from fields such as plastic surgery, burn treatment, dermatology, and radiation therapy to discuss new concepts, technologies, and standardized development in scar treatment.

As a specialized private medical institution focused on scar prevention and treatment, Bakang Medical was invited to participate in the Second China Scar Treatment Technology Progress Conference. President Xie Weiguo led a team of 10 representatives from Bakang to join experts from across the country in discussing the future direction of scar diagnosis and treatment.

The conference featured multiple thematic sessions covering advancements in scar treatment technology, standardized management, digital assessment, adjuvant radiotherapy, and rehabilitation management. The Bakang Medical team listened attentively to expert presentations, actively participated in academic discussions, and shared some of their clinical explorations based on their experience in specialized outpatient clinics.

On the first day of the conference, President Xie Weiguo of Bakang Medical was invited to host the session on "Ablative Photoelectric Treatment for Scars." In his presentation titled "Advances in Scar Reduction Surgery," he discussed the evolution of reduction surgery in the treatment of hypertrophic scars and keloids, sharing rich clinical cases and systematically reviewing the application scenarios, operational key points, and follow-up observations of techniques such as core excision and skin grafting.

On the same day, Dr. He Wen from the Chengdu branch of Bakang Medical presented "From Empirical Assessment to Precise Prognosis—A Digital Precision Diagnosis and Treatment Evaluation System for Scars." The report introduced Bakang's phased attempts in scar imaging assessment and follow-up management, aiming to provide more objective references for treatment planning and efficacy observation through quantitative recording of scar blood flow, thickness, and pigmentation.

On the second day of the conference, the "Expert Consensus on Standardized Adjuvant Radiotherapy for Keloids (2026 Edition)" was released. This consensus was organized by the China Human Health Technology Promotion Association and developed with the participation of multiple domestic experts, providing professional recommendations on key issues such as indications, dose fractionation, and protection requirements for adjuvant radiotherapy. President Sun Bianyou, as a member of the expert group, participated in the related work and further learned about the rigorous process of forming industry consensus.

Subsequently, President Sun Bianyou gave a presentation titled "How Can Specialized Chain Clinics Achieve Scale and Standardization?—The Operational Logic from Single Point Breakthrough to National Replication." The report shared Bakang's experience in developing from a single clinic to multiple locations, focusing on standardized thinking in diagnostic and therapeutic pathways, follow-up systems, talent cultivation, and quality control. For private medical institutions, standardization is not just a slogan but a foundation for long-term construction and an important prerequisite for ensuring patient experience and medical quality.

On the third day of the conference, President Sun Bianyou continued with a presentation titled "Treatment and Rehabilitation System for Pediatric Burn Scars," focusing on the special needs of pediatric burn scar patients. The report covered early wound healing, comprehensive intervention during the scar proliferation phase, and long-term rehabilitation management, sharing Bakang's clinical observations and service experiences in the full-cycle management of pediatric burn scars.

On the same day, Dr. He Wen from the Chengdu branch of Bakang Medical served as the host for the "Free Submission Speech 2" session. Dr. Wang Liang from the Wuhan branch presented "Methods and Management of In-Situ Skin Grafting for Keloids," introducing the application and postoperative management of this method in some keloid cases. This technique draws on the principles of burn skin grafting, processing and regrafting the excised tissue to reduce donor site damage while providing a treatment option for patients with large-area scars.

Participating in this conference was both an opportunity for Bakang Medical to showcase its clinical practices and a valuable learning experience. As a specialized private medical institution, Bakang recognizes the need to continuously learn from industry experts, peer institutions, and frontline clinical experiences. We aim to continuously accumulate knowledge in standardized diagnosis and treatment, digital assessment, long-term follow-up, and patient services, translating the insights gained from academic exchanges into more robust clinical capabilities.

In the future, Bakang Medical will continue to uphold the principle of "patient-centered care" and improve its service system around scar prevention, treatment, rehabilitation, and follow-up. With the guidance and support of industry experts and peers, Bakang is committed to participating in academic exchanges and clinical exploration with an open, pragmatic, and rigorous attitude, contributing to the development of scar prevention and treatment.